Our Scope

The advent of medical technology, combined with aging populations, results in healthcare costs representing an ever increasing proportion of GDP and government spending in most developed countries. Optimization of healthcare resources has therefore become a crucial and urgent challenge. In this context, the tools and methodologies provided by the disciplines of health economics / HTA are increasingly indispensable to the pharmaceutical/medical technology industries, as well as to governments and health insurance organizations. MYO covers all aspects of health economics/HTA, including:

Systematic Literature Review (SLR)

Cost-effectiveness models (original and/or country adaptation)

Budget Impact models (original and/or country adaptation)

Complete Value Dossers in support of reimbursement and Market Access

Authoring of ISPOR posters

Presentation of ISPOR posters

Authoring of full manuscripts

Publication of manuscripts in peer reviewed medical journals